Obicetrapib potassium
Obicetrapib (TA-8995; DEZ-001) potassium is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib potassium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib potassium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD).
For research use only. We do not sell to patients.
- CAS No.: 866399-90-8
- Formula: C32H30F9KN4O5
- Molecular Weight:760.69
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Chemical Information
-
CAS No. 866399-90-8
-
Molecular Weight 760.69
-
Formula C32H30F9KN4O5
-
SMILES
FC(F)(F)C1=CC(C(F)(F)F)=CC(CN(C2=NC=C(OCCCC(O[K])=O)C=N2)[C@@H]3C4=CC(C(F)(F)F)=CC=C4N([C@@H](C3)CC)C(OCC)=O)=C1
-
Synonyms
TA-8995 potassium; DEZ-001 potassium; AMG-899 potassium
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Obicetrapib potassium Related Classifications
Cat. No.: HY-18778B
Powered by Bioz
- Obicetrapib
- 866399-90-8
- TA-8995
- DEZ-001
- AMG-899
- TA8995
- TA 8995
- DEZ001
- DEZ 001
- AMG899
- AMG 899
- Apolipoprotein
- LDLR
- LPL Receptor
- CETP
- dyslipidaemia
- apolipoprotein B
- high-intensity statins
- apoB
- LDL-C
- high-density lipoprotein cholesterol
- cholesteryl ester transfer protein
- low-density lipoprotein cholesterol
- HDL-C
- Inhibitor
- inhibitor
- inhibit